Scp Investment, LP Clovis Oncology, Inc. Transaction History

Scp Investment, LP

  • $159 Million
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 15, 2018
SELL
$42.06 - $62.4 $294,420 - $436,800
-7,000 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$50.12 - $67.72 $350,840 - $474,040
7,000 New
7,000 $370,000

Others Institutions Holding CLVS

# of Institutions
1
Shares Held
166
Call Options Held
0
Put Options Held
0
View Full List

About Clovis Oncology, Inc.

CLVS Quotes by TradingView
  • Ticker CLVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 144,480,000
  • Market Cap $13M
  • Description
  • Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...
More about CLVS
Track This Portfolio

Track Scp Investment, LP Portfolio

Follow Scp Investment, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scp Investment, LP, based on Form 13F filings with the SEC.

News

Stay updated on Scp Investment, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email